ARMO BioSciences (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- February 11, 2016
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $50,000,000
Company Info
- Founding Year
- 2012
- Traction
- Demonstrated durable clinical responses in several types of cancer.
- Founders
- Peter Van Vlasselaer, PhD
- Company Description
- ARMO Biosciences is a biotechnology company that develops immune modulatory biologic therapeutics.
- Market
- Oncology
- Location
- Redwood City, California, USA
- Coinvestors
- Celgene Corporation, Clough Capital Partners, DAG Ventures, GVHBM Healthcare Investments, Industrial Investors Group, NanoDimension, OrbiMed Advisors